Alliancebernstein L.P. Cytosorbents Corp Transaction History

Alliancebernstein L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $96,096 - $175,812	-54,600 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.88 - $4.23 $288 - $423	100 Added 0.18%	54,600 $174,000
Q2 2021 Jul 30, 2021	BUY	$7.55 - $9.42 $16,610 - $20,724	2,200 Added 4.21%	54,500 $411,000
Q2 2020 Aug 13, 2020	BUY	$6.28 - $10.59 $50,868 - $85,779	8,100 Added 18.33%	52,300 $518,000
Q1 2020 May 14, 2020	BUY	$3.77 - $7.73 $83,694 - $171,606	22,200 Added 100.91%	44,200 $342,000

Q2 2019 Aug 14, 2019	BUY	$5.92 - $7.78 $13,024 - $17,116	2,200 Added 11.11%	22,000 $145,000
Q1 2019 May 14, 2019	BUY	$6.82 - $8.56 $59,334 - $74,472	8,700 Added 78.38%	19,800 $150,000
Q4 2018 Feb 13, 2019	BUY	$7.05 - $12.64 $78,255 - $140,304	11,100 New	11,100 $90,000

17.8M

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

Stay updated on Alliancebernstein L.P. with notifications on news.